Gastroduodenal Ulcer Clinical Trial
Official title:
A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers
A randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patient with high risk bleeding gastroduodenal ulcers.
This is a prospective randomized controlled trial to evaluate the efficacy of hemostatic forceps and bipolar electrocautery probes in patients with high-risk bleeding gastroduodenal ulcers. The primary outcome is comparing the hemostatic rates of the devices. Secondary outcomes are rebleeding rate at 7 and 30 days after index intervention, survival rate after intervention, procedure time for achieving hemostasis, number of units of infused blood, duration of hospitalization, and complications. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00778193 -
Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers
|
Phase 4 | |
| Not yet recruiting |
NCT04123899 -
BE Study of Gaster®D Tab 20mg (Manufacturer Changed)
|
N/A | |
| Completed |
NCT02175186 -
Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
|
Phase 4 | |
| Completed |
NCT03163680 -
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
|
||
| Not yet recruiting |
NCT02882477 -
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT02724150 -
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
|
Phase 4 |